KDNY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 rugp. 2023 @ 23:00):

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases...

Stats
Dzisiejszy wolumen	3.28M
Średni wolumen	2.04M
Kapitalizacja rynkowa	2.71B
EPS	$0 ( 2024-02-26 )
Następna data zysków	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.47
ATR14	$0.453 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-11	Thomas Dolca	Sell	13 300	Common Stock
2023-08-11	Thomas Dolca	Sell	23 522	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	5 948	Stock Option (Right to Buy)
2023-08-11	Thomas Dolca	Sell	13 300	Stock Option (Right to Buy)
2023-08-11	Oxtoby Andrew	Sell	160 000	Stock Option (Right to Buy)

INSIDER POWER
-96.04
Last 99 transactions
Buy: 289 232 \| Sell: 10 194 260

Wolumen Korelacja

Długi: 0.28 (neutral)

Krótki: 0.00 (neutral)

Signal:(78.495) Neutral

Aduro Biotech Inc Korelacja

10 Najbardziej pozytywne korelacje
KIN	0.983
SCPL	0.975
ABST	0.973
BWC	0.972
CDRO	0.971
NXGN	0.971
TXRH	0.962
IMGN	0.961
SRRA	0.961
ISEE	0.956

10 Najbardziej negatywne korelacje
CYAN	-0.967
PEAR	-0.96
SSP	-0.958
AUPH	-0.958
PYR	-0.957
SABR	-0.955
QDEL	-0.954
PENN	-0.953
PTE	-0.952
BRQS	-0.952

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aduro Biotech Inc Korelacja - Waluta/Towar

0.39
( neutral )

0.67
( moderate )

-0.22
( neutral )

-0.27
( neutral )

0.25
( neutral )

0.70
( moderate )

Aduro Biotech Inc Finanse

Annual	2022
Przychody:	$6.13M
Zysk brutto:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2022
Przychody:	$6.13M
Zysk brutto:	$4.41M (71.90 %)
EPS:	$-2.87

FY	2021
Przychody:	$51 625.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00226

FY	2020
Przychody:	$827 000
Zysk brutto:	$827 000 (100.00 %)
EPS:	$-6.20

Financial Reports:

No articles found.

Aduro Biotech Inc

Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

Aktualne aktualizacje dla Aduro Biotech Inc [KDNY]

Upcoming Earnings Alert